特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

世界における医薬品研究開発受託機関(CRO)市場の規模、シェア、動向分析

Healthcare Contract Research Organization Market Size, Share & Trends Analysis Report By Type (Drug Discovery, Pre-Clinical, Clinical), By Service (Clinical Monitoring, Data Management), And Segment Forecasts, 2020 - 2027

発行 Grand View Research, Inc. 商品コード 639957
出版日 ページ情報 英文 100 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=107.57円で換算しております。
世界における医薬品研究開発受託機関(CRO)市場の規模、シェア、動向分析 Healthcare Contract Research Organization Market Size, Share & Trends Analysis Report By Type (Drug Discovery, Pre-Clinical, Clinical), By Service (Clinical Monitoring, Data Management), And Segment Forecasts, 2020 - 2027
出版日: 2020年02月12日 ページ情報: 英文 100 Pages
概要

当レポートでは、世界の医薬品研究開発受託機関(CRO)市場について調査し、市場の動向とセグメント別動向、地域別予測、市場に参入する企業のプロファイルについてまとめています。

第1章 調査方法と調査範囲

第2章 エグゼクティブサマリー

第3章 市場の変数、動向、範囲

  • 市場直線見通し
  • 市場セグメンテーションと範囲
  • 浸透度と成長見通しマッピング
  • 治験
  • ユーザー展望分析
  • 法規制枠組み・償還シナリオ
  • 市場動向
    • 市場促進因子分析
    • 市場阻害因子分析
  • 市場分析ツール

第4章 タイプ別市場予測と動向分析

  • 市場シェア分析
  • セグメント概要
  • 市場規模と予測、動向分析
    • 創薬
    • 前臨床
    • 臨床

第5章 サービス別市場予測と動向分析

  • 市場シェア分析
  • セグメント概要
  • 市場規模と予測、動向分析
    • プロジェクトマネジメント/臨床サプライマネジメント
    • データマネジメント
    • 法規制・医務アウトソーシング
    • メディカルライティング
    • 臨床モニタリング
    • 品質マネジメント/保証
    • バイオ統計学
    • 投資家支払い
    • 試験所
    • 患者・サイト募集
    • 技術
    • その他

第6章 地域別予測と動向分析

  • 市場シェア
  • セグメント概要
  • 地域別市場概要
  • 主要企業リスト
  • SWOT分析
  • 市場規模と予測、動向分析
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ

第7章 競合環境

  • 近年の発展と影響分析
  • 戦略枠組み/競合分類
  • ベンダー環境
  • 戦略マッピング
  • 公的企業
  • 民間企業
  • CRO市場シェア
  • モデル定性分析
  • 企業プロファイル
図表

List of Tables

  • Table 1 North America Healthcare CRO market, by type, 2016 - 2027 (USD Million)
  • Table 2 North America Healthcare CRO market, by service, 2016 - 2027 (USD Million)
  • Table 3 U.S. Healthcare CRO market, by type, 2016 - 2027 (USD Million)
  • Table 4 U.S. Healthcare CRO market, by service, 2016 - 2027 (USD Million)
  • Table 5 Canada Healthcare CRO market, by type, 2016 - 2027 (USD Million)
  • Table 6 Canada Healthcare CRO market, by service, 2016 - 2027 (USD Million)
  • Table 7 Europe Healthcare CRO market, by type, 2016 - 2027 (USD Million)
  • Table 8 Europe Healthcare CRO market, by service, 2016 - 2027 (USD Million)
  • Table 9 U.K. Healthcare CRO market, by type, 2016 - 2027 (USD Million)
  • Table 10 U.K. Healthcare CRO market, by service, 2016 - 2027 (USD Million)
  • Table 11 Germany Healthcare CRO market, by type, 2016 - 2027 (USD Million)
  • Table 12 Germany Healthcare CRO market, by service, 2016 - 2027 (USD Million)
  • Table 13 France Healthcare CRO market, by type, 2016 - 2027 (USD Million)
  • Table 14 France Healthcare CRO market, by service, 2016 - 2027 (USD Million)
  • Table 15 Italy Healthcare CRO market, by type, 2016 - 2027 (USD Million)
  • Table 16 Italy Healthcare CRO market, by service, 2016 - 2027 (USD Million)
  • Table 17 Spain Healthcare CRO market, by type, 2016 - 2027 (USD Million)
  • Table 18 Spain Healthcare CRO market, by service, 2016 - 2027 (USD Million)
  • Table 19 Netherlands Healthcare CRO market, by type, 2016 - 2027 (USD Million)
  • Table 20 Netherlands Healthcare CRO market, by service, 2016 - 2027 (USD Million)
  • Table 21 Switzerland Healthcare CRO market, by type, 2016 - 2027 (USD Million)
  • Table 22 Switzerland Healthcare CRO market, by service, 2016 - 2027 (USD Million)
  • Table 23 Belgium Healthcare CRO market, by type, 2016 - 2027 (USD Million)
  • Table 24 Belgium Healthcare CRO market, by service, 2016 - 2027 (USD Million)
  • Table 25 Austria Healthcare CRO market, by type, 2016 - 2027 (USD Million)
  • Table 26 Austria Healthcare CRO market, by service, 2016 - 2027 (USD Million)
  • Table 27 Asia Pacific Healthcare CRO market, by type, 2016 - 2027 (USD Million)
  • Table 28 Asia Pacific Healthcare CRO market, by service, 2016 - 2027 (USD Million)
  • Table 29 Japan Healthcare CRO market, by type, 2016 - 2027 (USD Million)
  • Table 30 Japan Healthcare CRO market, by service, 2016 - 2027 (USD Million)
  • Table 31 China Healthcare CRO market, by type, 2016 - 2027 (USD Million)
  • Table 32 China Healthcare CRO market, by service, 2016 - 2027 (USD Million)
  • Table 33 India Healthcare CRO market, by type, 2016 - 2027 (USD Million)
  • Table 34 India Healthcare CRO market, by service, 2016 - 2027 (USD Million)
  • Table 35 Thailand Healthcare CRO market, by type, 2016 - 2027 (USD Million)
  • Table 36 Thailand Healthcare CRO market, by service, 2016 - 2027 (USD Million)
  • Table 37 South Korea Healthcare CRO market, by type, 2016 - 2027 (USD Million)
  • Table 38 South Korea Healthcare CRO market, by service, 2016 - 2027 (USD Million)
  • Table 39 Malaysia Healthcare CRO market, by type, 2016 - 2027 (USD Million)
  • Table 40 Malaysia Healthcare CRO market, by service, 2016 - 2027 (USD Million)
  • Table 41 Taiwan Healthcare CRO market, by type, 2016 - 2027 (USD Million)
  • Table 42 Taiwan Healthcare CRO market, by service, 2016 - 2027 (USD Million)
  • Table 43 Indonesia Healthcare CRO market, by type, 2016 - 2027 (USD Million)
  • Table 44 Indonesia Healthcare CRO market, by service, 2016 - 2027 (USD Million)
  • Table 45 Singapore Healthcare CRO market, by type, 2016 - 2027 (USD Million)
  • Table 46 Singapore Healthcare CRO market, by service, 2016 - 2027 (USD Million)
  • Table 45 Australia Healthcare CRO market, by type, 2016 - 2027 (USD Million)
  • Table 46 Australia Healthcare CRO market, by service, 2016 - 2027 (USD Million)
  • Table 47 Latin America Healthcare CRO market, by type, 2016 - 2027 (USD Million)
  • Table 48 Latin America Healthcare CRO market, by service, 2016 - 2027 (USD Million)
  • Table 49 Brazil Healthcare CRO market, by type, 2016 - 2027 (USD Million)
  • Table 50 Brazil Healthcare CRO market, by service, 2016 - 2027 (USD Million)
  • Table 51 Mexico Healthcare CRO market, by type, 2016 - 2027 (USD Million)
  • Table 52 Mexico Healthcare CRO market, by service, 2016 - 2027 (USD Million)
  • Table 53 Argentina Healthcare CRO market, by type, 2016 - 2027 (USD Million)
  • Table 54 Argentina Healthcare CRO market, by service, 2016 - 2027 (USD Million)
  • Table 55 Colombia Healthcare CRO market, by type, 2016 - 2027 (USD Million)
  • Table 56 Colombia Healthcare CRO market, by service, 2016 - 2027 (USD Million)
  • Table 57 Chile Healthcare CRO market, by type, 2016 - 2027 (USD Million)
  • Table 58 Chile Healthcare CRO market, by service, 2016 - 2027 (USD Million)
  • Table 59 MEA Healthcare CRO market, by type, 2016 - 2027 (USD Million)
  • Table 60 MEA Healthcare CRO market, by service, 2016 - 2027 (USD Million)
  • Table 61 South Africa Healthcare CRO market, by type, 2016 - 2027 (USD Million)
  • Table 62 South Africa Healthcare CRO market, by service, 2016 - 2027 (USD Million)
  • Table 63 Saudi Arabia Healthcare CRO market, by type, 2016 - 2027 (USD Million)
  • Table 64 Saudi Arabia Healthcare CRO market, by service, 2016 - 2027 (USD Million)
  • Table 65 UAE Healthcare CRO market, by type, 2016 - 2027 (USD Million)
  • Table 66 UAE Healthcare CRO market, by service, 2016 - 2027 (USD Million)
  • Table 67 Israel Healthcare CRO market, by type, 2016 - 2027 (USD Million)
  • Table 68 Israel Healthcare CRO market, by service, 2016 - 2027 (USD Million)
  • Table 69 Iran Healthcare CRO market, by type, 2016 - 2027 (USD Million)
  • Table 70 Iran Healthcare CRO market, by service, 2016 - 2027 (USD Million)

List of Figures

  • Figure 1 Healthcare Contract Research Organization (CRO) Market Segmentation
  • Figure 2 Global Healthcare Contract Research Organization (CRO) Market, 2016 - 2027 (USD Million)
  • Figure 3 Healthcare Contract Research Organization (CRO) Market Porter's Analysis
  • Figure 4 Healthcare Contract Research Organization (CRO) Market Share,2019
  • Figure 5 Healthcare Contract Research Organization (CRO) Market PESTEL Analysis
  • Figure 6 Healthcare Contract Research Organization (CRO) Market Competitive Landscape, 2019
  • Figure 7 Healthcare Contract Research Organization (CRO)Revenue, Share By Type, 2019 & 2027
  • Figure 8 Drug Discovery Market, 2016 - 2027 (USD Million)
  • Figure 9Target Validation Market, 2016 - 2027 (USD Million)
  • Figure 10 Lead Identification Market, 2016 - 2027 (USD Million)
  • Figure 11 Lead Optimization Market, 2016 - 2027 (USD Million)
  • Figure 12 Pre-Clinical Market, 2016 - 2027 (USD Million)
  • Figure 13 Clinical Market, 2016 - 2027 (USD Million)
  • Figure 14 Phase I Trial Services Market, 2016 - 2027 (USD Million)
  • Figure 15 Phase II Trial Services Market, 2016 - 2027 (USD Million)
  • Figure 16 Phase III Trial Services, 2016 - 2027 (USD Million)
  • Figure 17 Phase IV Trial Services Market, 2016 - 2027 (USD Million)
  • Figure 18 Healthcare Contract Research Organization (CRO) Revenue Share, by Service, 2019 & 2027
  • Figure 19 Project Management/Clinical Supply Management Market, 2016 - 2027 (USD Million)
  • Figure 20 Clinical data management flow
  • Figure 21 Data Management Outsourcing Market, 2016 - 2027 (USD Million)
  • Figure 22 Regulatory/Medical Affairs Outsourcing Services, 2016 - 2027 (USD Million)
  • Figure 23 Medical Writing Outsourcing Market, 2016 - 2027 (USD Million)
  • Figure 24 Clinical Monitoring Outsourcing Market, 2016 - 2027 (USD Million)
  • Figure 25 Quality Management/ Assurance Outsourcing Market, 2016 - 2027 (USD Million)
  • Figure 26 Bio-statistics Market, 2016 - 2027 (USD Million)
  • Figure 27 Investigator Payments Outsourcing Market, 2016 - 2027 (USD Million)
  • Figure 28 Laboratory Outsourcing Market, 2016 - 2027 (USD Million)
  • Figure 29 Strategic initiatives with positive impact on patient recruitment
  • Figure 30 Patient and Site Recruitment Outsourcing Market, 2016 - 2027 (USD Million)
  • Figure 31 Technology Outsourcing Market, 2016 - 2027 (USD Million)
  • Figure 32 Others, 2016 - 2027 (USD Million)
  • Figure 33 Healthcare Contract Research Organization (CRO) Revenue Share, By Region, 2019 & 2027
  • Figure 34 North America Healthcare Contract Research Organization (CRO) Market, 2016 - 2027 (USD Million)
  • Figure 35 U.S. Healthcare Contract Research Organization (CRO) Market, 2016 - 2027 (USD Million)
  • Figure 36 Canada Healthcare Contract Research Organization (CRO),Market, 2016 - 2027 (USD Million)
  • Figure 37 Europe Healthcare Contract Research Organization (CRO) Market, 2016 - 2027 (USD Million)
  • Figure 38 U.K. Healthcare Contract Research Organization (CRO) Market, 2016 - 2027 (USD Million)
  • Figure 39 Germany Healthcare Contract Research Organization (CRO) Market, 2016 - 2027 (USD Million)
  • Figure 40 France Healthcare Contract Research Organization (CRO) Market, 2016 - 2027 (USD Million)
  • Figure 41 Italy Healthcare Contract Research Organization (CRO) Market, 2016 - 2027 (USD Million)
  • Figure 42 Spain Healthcare Contract Research Organization (CRO) Market, 2016 - 2027 (USD Million)
  • Figure 43 Switzerland Healthcare Contract Research Organization (CRO) Market, 2016 - 2027 (USD Million)
  • Figure 44 Netherlands Healthcare Contract Research Organization (CRO) Market, 2016 - 2027 (USD Million)
  • Figure 45 Belgium Healthcare Contract Research Organization (CRO) Market, 2016 - 2027 (USD Million)
  • Figure 46 Austria Healthcare Contract Research Organization (CRO) Market, 2016 - 2027 (USD Million)
  • Figure 47 Asia Pacific Healthcare Contract Research Organization (CRO) Market, 2016 - 2027 (USD Million)
  • Figure 48 India Healthcare Contract Research Organization (CRO) Market, 2016 - 2027 (USD Million)
  • Figure 49 China Healthcare Contract Research Organization (CRO) Market, 2016 - 2027 (USD Million)
  • Figure 50 Japan Healthcare Contract Research Organization (CRO) Market, 2016 - 2027 (USD Million)
  • Figure 51 Indonesia Healthcare Contract Research Organization (CRO) Market, 2016 - 2027 (USD Million)
  • Figure 52 Taiwan Healthcare Contract Research Organization (CRO) Market, 2016 - 2027 (USD Million)
  • Figure 53 Malaysia Healthcare Contract Research Organization (CRO) Market, 2016 - 2027 (USD Million)
  • Figure 54 Singapore Healthcare Contract Research Organization (CRO) Market, 2016 - 2027 (USD Million)
  • Figure 55 Australia Healthcare Contract Research Organization (CRO) Market, 2016 - 2027 (USD Million)
  • Figure 56 Thailand Healthcare Contract Research Organization (CRO) Market, 2016 - 2027 (USD Million)
  • Figure 57 Korea Healthcare Contract Research Organization (CRO) Market, 2016 - 2027 (USD Million)
  • Figure 58 Latin America Healthcare Contract Research Organization (CRO) Market, 2016 - 2027 (USD Million)
  • Figure 59 Brazil Healthcare Contract Research Organization (CRO) Market, 2016 - 2027 (USD Million)
  • Figure 60 Mexico Healthcare Contract Research Organization (CRO) Market, 2016 - 2027 (USD Million)
  • Figure 61 Argentina Healthcare Contract Research Organization (CRO) Market, 2016 - 2027 (USD Million)
  • Figure 62 Colombia Healthcare Contract Research Organization (CRO) Market, 2016 - 2027 (USD Million)
  • Figure 63 Chile Healthcare Contract Research Organization (CRO) Market, 2016 - 2027 (USD Million)
  • Figure 64 MEA Healthcare Contract Research Organization (CRO) Market, 2016 - 2027 (USD Million)
  • Figure 65 South Africa Healthcare Contract Research Organization (CRO) Market, 2016 - 2027 (USD Million)
  • Figure 66 Saudi Arabia Healthcare Contract Research Organization (CRO) Market, 2016 - 2027 (USD Million)
  • Figure 67 UAE Healthcare Contract Research Organization (CRO) Market, 2016 - 2027 (USD Million)
  • Figure 68 Iran Healthcare Contract Research Organization (CRO) Market, 2016 - 2027 (USD Million)
  • Figure 69 Israel Healthcare Contract Research Organization (CRO) Market, 2016 - 2027 (USD Million)
目次
Product Code: 978-1-68038-688-2

The global healthcare contract research organization market size is expected to reach USD 62.1 billion by 2027, according to a new study by Grand View Research Inc. registering a CAGR of 6.6% over the forecast period. Increasing cost of drug development is expected to drive market demand over the forecast period. Rising cost of clinical trials and challenges pertaining to patient recruitment have led biopharmaceutical companies to turn to regions like Central and Eastern Europe, Asia Pacific, Latin America, and Middle East for cost savings and quick patient recruitment.

The alarming rise in incidence rate of chronic as well as infectious diseases such as cancer and Alzheimer's is anticipated to spur demand for effective and safe treatment options. For instance, according to WHO, chronic diseases such as respiratory disorders, diabetes, cancer, cardiovascular diseases, and other life-threatening diseases are likely to account for about 73.0% of global deaths and about 60.0% of global disease burden by 2020. This is compelling an increasing number of healthcare companies to turn to contract research organizations (CROs) for the numerous benefits they offer.

In addition, growing pressure on industry players to follow stringent timelines has increased the demand for outsourcing research activities to contract research organizations. Some government organizations are also outsourcing their clinical trial activities to CROs so that they can carry out clinical trials with the required infrastructure, expertise, and minimize their cost and timelines. For instance, in 2015, the Canadian Federal Budget made an investment of USD 1.33 billion for the Canada Foundation for Innovation (CFI).

Further key findings from the study suggest:

  • Clinical trial services dominated the healthcare CRO market in 2019 owing to the fact that it comprises four elaborate phases, including human subjects. ICON GPHS, formerly ClinicalRM, provides staffing and clinical development services to multiple agencies such as NGOs, the U.S. Government, academic institutions, and other healthcare organizations
  • North America held a significant market share in 2019 due to the presence of several global players, who invest a major part of their revenue in research activities
  • Asia Pacific is anticipated to witness lucrative growth over the forecast period due to the reduced cost it offers in comparison to U.S and other developed economies. China, Japan and India are projected to witness tremendous growth in the contract research organization market owing to high disease prevalence

Key players in the market include IQVIA, Covance, Pharmaceutical Product Development, LLC (PPD), PAREXEL, Pharmaron, Syneos Health, Charles River Laboratories (CRL), ICON plc, Medidata Solutions, and GVK Biosciences Private Limited.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market segmentation & scope
  • 1.2. Information procurement
    • 1.2.1. Purchased database
    • 1.2.2. GVR's internal database
    • 1.2.3. Secondary sources & third-party perspectives
    • 1.2.4. Primary research
  • 1.3. Information analysis
    • 1.3.1. Data analysis models
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Healthcare CRO Market Variables, Trends & Scope

  • 3.1. Market Lineage outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Product Pipeline Analysis
  • 3.4. Regulatory Framework
    • 3.4.1. Reimbursement framework
    • 3.4.2. Standards & Compliances
  • 3.5. Market Dynamics
    • 3.5.1. Market Driver Analysis
    • 3.5.2. Market Restraint Analysis
  • 3.6. Healthcare CRO: Market Analysis Tools
    • 3.6.1. Industry Analysis - Porter's
      • 3.6.1.1. Supplier Power:
      • 3.6.1.2. Buyer Power
      • 3.6.1.3. Substitution Threat
      • 3.6.1.4. Threat from new entrant:
      • 3.6.1.5. Competitive rivalry:
    • 3.6.2. PESTEL Analysis
      • 3.6.2.1. Political Landscape
      • 3.6.2.2. Environmental Landscape
      • 3.6.2.3. Social Landscape
      • 3.6.2.4. Technology Landscape
      • 3.6.2.5. Legal Landscape
    • 3.6.3. Major Deals & Strategic Alliances Analysis
      • 3.6.3.1. Joint Ventures
      • 3.6.3.2. Mergers & Acquisitions
      • 3.6.3.3. Licensing & Partnership
      • 3.6.3.4. Technology Collaborations
      • 3.6.3.5. Strategic Divestments

Chapter 4. Healthcare CRO Market: Segment Analysis, By Type, 2016 - 2027 (USD Million)

  • 4.1. Type market share analysis, 2019 & 2027
  • 4.2. Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following
    • 4.3.1. Drug Discovery
      • 4.3.1.1. Target validation
      • 4.3.1.2. Lead identification
      • 4.3.1.3. Lead optimization
    • 4.3.2. Pre-Clinical
    • 4.3.3. Clinical
      • 4.3.3.1. Phase I trial services
      • 4.3.3.2. Phase II trial services
      • 4.3.3.3. Phase III trial services
      • 4.3.3.4. Phase IV trial services

Chapter 5. Healthcare CRO Market: Segment Analysis, By Service, 2016 - 2027 (USD Million)

  • 5.1. Service market share analysis, 2019 & 2027
  • 5.2. Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following
    • 5.3.1. Project Management/Clinical Supply Management
    • 5.3.2. Data Management
    • 5.3.3. Regulatory/Medical Affairs
    • 5.3.4. Medical Writing
    • 5.3.5. Clinical Monitoring
    • 5.3.6. Quality Management/ Assurance
    • 5.3.7. Bio-statistics
    • 5.3.8. Investigator Payments
    • 5.3.9. Laboratory
    • 5.3.10. Patient and Site Recruitment
    • 5.3.11. Technology
    • 5.3.12. Others

Chapter 6. Healthcare CRO Market: Regional Market Analysis, 2016 - 2027 (USD Million)

  • 6.1. Regional market share analysis, 2019 & 2027
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size, & Forecasts, and Trend Analysis, 2016 to 2027:
  • 6.4. North America
    • 6.4.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
    • 6.4.2. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
    • 6.4.3. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 6.4.4. U.S.
      • 6.4.4.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
      • 6.4.4.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 6.4.5. Canada
      • 6.4.5.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
      • 6.4.5.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
  • 6.5. Europe
    • 6.5.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
    • 6.5.2. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
    • 6.5.3. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 6.5.4. Germany
      • 6.5.4.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
      • 6.5.4.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 6.5.5. U.K.
      • 6.5.5.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
      • 6.5.5.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 6.5.6. France
      • 6.5.6.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
      • 6.5.6.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 6.5.7. Italy
      • 6.5.7.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
      • 6.5.7.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 6.5.8. Spain
      • 6.5.8.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
      • 6.5.8.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 6.5.9. Switzerland
      • 6.5.9.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
      • 6.5.9.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 6.5.10. Netherlands
      • 6.5.10.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
      • 6.5.10.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 6.5.11. Belgium
      • 6.5.11.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
      • 6.5.11.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 6.5.12. Austria
      • 6.5.12.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
      • 6.5.12.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
    • 6.6.2. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
    • 6.6.3. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 6.6.4. China
      • 6.6.4.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
      • 6.6.4.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 6.6.5. Japan
      • 6.6.5.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
      • 6.6.5.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 6.6.6. India
      • 6.6.6.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
      • 6.6.6.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 6.6.7. Australia
      • 6.6.7.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
      • 6.6.7.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 6.6.8. Korea
      • 6.6.8.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
      • 6.6.8.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 6.6.9. Thailand
      • 6.6.9.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
      • 6.6.9.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 6.6.10. Malaysia
      • 6.6.10.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
      • 6.6.10.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 6.6.11. Singapore
      • 6.6.11.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
      • 6.6.11.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 6.6.12. Indonesia
      • 6.6.12.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
      • 6.6.12.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 6.6.13. Taiwan
      • 6.6.13.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
      • 6.6.13.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
    • 6.7.2. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
    • 6.7.3. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 6.7.4. Brazil
      • 6.7.4.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
      • 6.7.4.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 6.7.5. Mexico
      • 6.7.5.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
      • 6.7.5.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 6.7.6. Argentina
      • 6.7.6.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
      • 6.7.6.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 6.7.7. Colombia
      • 6.7.7.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
      • 6.7.7.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 6.7.8. Chile
      • 6.7.8.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
      • 6.7.8.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
  • 6.8. Middle East and Africa
    • 6.8.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
    • 6.8.2. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
    • 6.8.3. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 6.8.4. South Africa
      • 6.8.4.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
      • 6.8.4.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 6.8.5. Saudi Arabia
      • 6.8.5.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
      • 6.8.5.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 6.8.6. UAE
      • 6.8.6.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
      • 6.8.6.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 6.8.7. Israel
      • 6.8.7.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
      • 6.8.7.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 6.8.8. Iran
      • 6.8.8.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
      • 6.8.8.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)

Chapter 7. Healthcare CRO Market - Competitive Analysis

  • 7.1. Key companies profiled
    • 7.1.1. IQVIA
      • 7.1.1.1. Company Overview
      • 7.1.1.2. Financial Performance
      • 7.1.1.3. Product Benchmarking
      • 7.1.1.4. Strategic Initiatives
    • 7.1.2. Covance Inc.
      • 7.1.2.1. Company Overview
      • 7.1.2.2. Financial Performance
      • 7.1.2.3. Product Benchmarking
      • 7.1.2.4. Strategic Initiatives
    • 7.1.3. Pharmaceutical Product Development, LLC (PPD)
      • 7.1.3.1. Company Overview
      • 7.1.3.2. Financial Performance
      • 7.1.3.3. Product Benchmarking
      • 7.1.3.4. Strategic Initiatives
    • 7.1.4. PAREXEL
      • 7.1.4.1. Company Overview
      • 7.1.4.2. Financial Performance
      • 7.1.4.3. Product Benchmarking
      • 7.1.4.4. Strategic Initiatives
    • 7.1.5. Charles River Laboratories
      • 7.1.5.1. Company Overview
      • 7.1.5.2. Financial Performance
      • 7.1.5.3. Product Benchmarking
      • 7.1.5.4. Strategic Initiatives
    • 7.1.6. ICON, plc.
      • 7.1.6.1. Company Overview
      • 7.1.6.2. Financial Performance
      • 7.1.6.3. Product Benchmarking
      • 7.1.6.4. Strategic Initiatives
    • 7.1.7. Medidata Solutions, Inc.
      • 7.1.7.1. Company Overview
      • 7.1.7.2. Financial Performance
      • 7.1.7.3. Product Benchmarking
      • 7.1.7.4. Strategic Initiatives
    • 7.1.8. Syneos Health.
      • 7.1.8.1. Company Overview
      • 7.1.8.2. Financial Performance
      • 7.1.8.3. Product Benchmarking
      • 7.1.8.4. Strategic Initiatives
    • 7.1.9. Pharmaron.
      • 7.1.9.1. Company Overview
      • 7.1.9.2. Financial Performance
      • 7.1.9.3. Product Benchmarking
      • 7.1.9.4. Strategic Initiatives
    • 7.1.10. GVK Biosciences Private Limited.
      • 7.1.10.1. Company Overview
      • 7.1.10.2. Financial Performance
      • 7.1.10.3. Product Benchmarking
      • 7.1.10.4. Strategic Initiatives